Nordic Bioscience works in preclinical and clinical drug development. They specialise in precision medicine using unique biomarker technologies to stratify patient populations and inform clinical trial design.

TherapeutAix and Nordic Bioscience liaise with biotech and pharmaceutical clients to build pre-clinical disease understanding and develop biomarker-led strategies for delivery of early clinical proof of concept. In a portfolio setting, we identify projects most suitable for clinical development.